Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid (Q48749039)

15 February 2018

review article

1 reference

title

Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid (English)

1 reference

15 February 2018

0 references

Judith Schuster

1

1 reference

15 February 2018

Susanne Aileen Funke

series ordinal

2

1 reference

15 February 2018

publication date

7 May 2016

1 reference

15 February 2018

Journal of Alzheimer's Disease

published in

1 reference

15 February 2018

volume

53

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

53-67

1 reference

15 February 2018

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

21 January 2018

Amyloid-beta aggregation

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Regenerable and Simultaneous Surface Plasmon Resonance Detection of Aβ(1−40) and Aβ(1−42) Peptides in Cerebrospinal Fluids with Signal Amplification by Streptavidin Conjugated to an N-Terminus-Specific Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

A sensitive aβ oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Single-particle detection system for Abeta aggregates: adaptation of surface-fluorescence intensity distribution analysis to laser scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Cyclic amplification of protein misfolding: application to prion-related disorders and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Localized Surface Plasmon Resonance Biosensing: Current Challenges and Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Peptide-based electrochemical biosensor for amyloid β 1-42 soluble oligomer assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

A label-free electrical impedimetric biosensor for the specific detection of Alzheimer's amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Biological CSF markers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aβ oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Amyloid oligomer conformation in a group of natively folded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

An Ultrasensitive Assay for Diagnosis of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

Single particle detection of Aβ aggregates associated with Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-151029

21 January 2018

Identifiers

DOI

10.3233/JAD-151029

1 reference

15 February 2018

1 reference

15 February 2018